Terms: = Kidney tumors AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1
1645 results:
1. A Cerebellar Tumor-to-Tumor Metastasis in a Patient With Von Hippel-Lindau Disease.
Wang T; Liu L; Rampisela D; Dong X; Keith KA; Benardete EA; Shan FY
Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):244-248. PubMed ID: 38712587
[TBL] [Abstract] [Full Text] [Related]
2. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.
Purdue MP; Dutta D; Machiela MJ; Gorman BR; Winter T; Okuhara D; Cleland S; Ferreiro-Iglesias A; Scheet P; Liu A; Wu C; Antwi SO; Larkin J; Zequi SC; Sun M; Hikino K; Hajiran A; Lawson KA; Cárcano F; Blanchet O; Shuch B; Nepple KG; Margue G; Sundi D; Diver WR; Folgueira MAAK; van Bokhoven A; Neffa F; Brown KM; Hofmann JN; Rhee J; Yeager M; Cole NR; Hicks BD; Manning MR; Hutchinson AA; Rothman N; Huang WY; Linehan WM; Lori A; Ferragu M; Zidane-Marinnes M; Serrano SV; Magnabosco WJ; ; Vilas A; Decia R; Carusso F; Graham LS; Anderson K; Bilen MA; Arciero C; Pellegrin I; Ricard S; ; Scelo G; Banks RE; Vasudev NS; Soomro N; Stewart GD; Adeyoju A; Bromage S; Hrouda D; Gibbons N; Patel P; Sullivan M; Protheroe A; Nugent FI; Fournier MJ; Zhang X; Martin LJ; Komisarenko M; Eisen T; Cunningham SA; Connolly DC; Uzzo RG; Zaridze D; Mukeria A; Holcatova I; Hornakova A; Foretova L; Janout V; Mates D; Jinga V; Rascu S; Mijuskovic M; Savic S; Milosavljevic S; Gaborieau V; Abedi-Ardekani B; McKay J; Johansson M; Phouthavongsy L; Hayman L; Li J; Lungu I; Bezerra SM; Souza AG; Sares CTG; Reis RB; Gallucci FP; Cordeiro MD; Pomerantz M; Lee GM; Freedman ML; Jeong A; Greenberg SE; Sanchez A; Thompson RH; Sharma V; Thiel DD; Ball CT; Abreu D; Lam ET; Nahas WC; Master VA; Patel AV; Bernhard JC; Freedman ND; Bigot P; Reis RM; Colli LM; Finelli A; Manley BJ; Terao C; Choueiri TK; Carraro DM; Houlston R; Eckel-Passow JE; Abbosh PH; Ganna A; Brennan P; Gu J; Chanock SJ
Nat Genet; 2024 May; 56(5):809-818. PubMed ID: 38671320
[TBL] [Abstract] [Full Text] [Related]
3. [Modern view on the problem of diagnostics of renal angiomioadenomatous tumor].
Osmanov Y I; Kogan E A; Gadzhieva Z K; Radenska-Lopovok S G; Prochenko D D
Urologiia; 2024 Mar; (1):92-95. PubMed ID: 38650412
[TBL] [Abstract] [Full Text] [Related]
4. vhl loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis.
Wolf MM; Madden MZ; Arner EN; Bader JE; Ye X; Vlach L; Tigue ML; Landis MD; Jonker PB; Hatem Z; Steiner KK; Gaines DK; Reinfeld BI; Hathaway ES; Xin F; Tantawy MN; Haake SM; Jonasch E; Muir A; Weiss VL; Beckermann KE; Rathmell WK; Rathmell JC
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618956
[TBL] [Abstract] [Full Text] [Related]
5. vhl governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas.
Lee H; Zhuang L; Gan B
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618953
[TBL] [Abstract] [Full Text] [Related]
6. Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis.
Zhang C; Yu M; Hepperla AJ; Zhang Z; Raj R; Zhong H; Zhou J; Hu L; Fang J; Liu H; Liang Q; Jia L; Liao C; Xi S; Simon JM; Xu K; Liu Z; Nam Y; Kapur P; Zhang Q
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618952
[TBL] [Abstract] [Full Text] [Related]
7. vhl mutation drives human clear cell renal cell carcinoma progression through PI3K/AKT-dependent cholesteryl ester accumulation.
Zhang S; Fang T; He Y; Feng W; Yu Z; Zheng Y; Zhang C; Hu S; Liu Z; Liu J; Yu J; Zhang H; He A; Gong Y; He Z; Yang K; Xi Z; Yu W; Zhou L; Yao L; Yue S
EBioMedicine; 2024 May; 103():105070. PubMed ID: 38564827
[TBL] [Abstract] [Full Text] [Related]
8. Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients-Real-World Experience in a Single-Center Retrospective Study and Narrative Review.
Domański P; Piętak M; Staneta S; Fortuniak W; Kruczyk B; Kobiernik A; Bakuła P; Mydlak A; Demkow T; Sikora-Kupis B; Dumnicka P; Kucharz J
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541124
[No Abstract] [Full Text] [Related]
9. Mice with renal-specific alterations of stem cell-associated signaling develop symptoms of chronic kidney disease but surprisingly no tumors.
Myszczyszyn A; Popp O; Kunz S; Sporbert A; Jung S; Penning LC; Fendler A; Mertins P; Birchmeier W
PLoS One; 2024; 19(3):e0282938. PubMed ID: 38512983
[TBL] [Abstract] [Full Text] [Related]
10. DCLRE1B/Apollo germline mutations associated with renal cell carcinoma impair telomere protection.
Bories C; Lejour T; Adolphe F; Kermasson L; Couvé S; Tanguy L; Luszczewska G; Watzky M; Poillerat V; Garnier P; Groisman R; Ferlicot S; Richard S; Saparbaev M; Revy P; Gad S; Renaud F
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167107. PubMed ID: 38430974
[TBL] [Abstract] [Full Text] [Related]
11. Vascular, adipose tissue, and/or calyceal invasion in clear cell tubulopapillary renal cell tumour: potentially problematic diagnostic scenarios.
Sangoi AR; Tsai H; Harik L; Mahlow J; Tretiakova M; Williamson SR; Hirsch MS
Histopathology; 2024 Jun; 84(7):1167-1177. PubMed ID: 38422612
[TBL] [Abstract] [Full Text] [Related]
12. Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer.
Musleh Ud Din S; Streit SG; Huynh BT; Hana C; Abraham AN; Hussein A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396737
[TBL] [Abstract] [Full Text] [Related]
13. Hereditary Renal Cancer Syndromes.
Yanus GA; Kuligina ES; Imyanitov EN
Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390862
[TBL] [Abstract] [Full Text] [Related]
14. Identification of genomic drivers for the therapeutic response of Cabozantinib in patients with metastatic renal cell carcinoma.
Borkowetz A; Sommer U; Baretton G; Gruellich C; Bürk BT; Erb HHH; Thomas C;
World J Urol; 2024 Feb; 42(1):94. PubMed ID: 38386122
[TBL] [Abstract] [Full Text] [Related]
15. CT-derived radiomics predict the growth rate of renal tumours in von Hippel-Lindau syndrome.
Singh S; Dehghani Firouzabadi F; Chaurasia A; Homayounieh F; Ball MW; Huda F; Turkbey EB; Linehan WM; Malayeri AA
Clin Radiol; 2024 May; 79(5):e675-e681. PubMed ID: 38383255
[TBL] [Abstract] [Full Text] [Related]
16. vhl suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation.
Wang Z; Yan M; Ye L; Zhou Q; Duan Y; Jiang H; Wang L; Ouyang Y; Zhang H; Shen Y; Ji G; Chen X; Tian Q; Xiao L; Wu Q; Meng Y; Liu G; Ma L; Lei B; Lu Z; Xu D
EMBO J; 2024 Mar; 43(6):931-955. PubMed ID: 38360997
[TBL] [Abstract] [Full Text] [Related]
17. A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway.
Huang B; Ren J; Ma Q; Yang F; Pan X; Zhang Y; Liu Y; Wang C; Zhang D; Wei L; Ran L; Zhao H; Liang C; Wang X; Wang S; Li H; Ning H; Ran A; Li W; Wang Y; Xiao B
Mol Cancer; 2024 Feb; 23(1):34. PubMed ID: 38360682
[TBL] [Abstract] [Full Text] [Related]
18. Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma.
Tian J; Luo J; Zeng X; Ke C; Wang Y; Liu Z; Li L; Zhang Y; Hu Z; Yang C
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38355278
[TBL] [Abstract] [Full Text] [Related]
19. kidney scoring surveillance: predictive machine learning models for clear cell renal cell carcinoma growth using MRI.
Yazdian Anari P; Zahergivar A; Gopal N; Chaurasia A; Lay N; Ball MW; Turkbey B; Turkbey E; Jones EC; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2024 Apr; 49(4):1202-1209. PubMed ID: 38347265
[TBL] [Abstract] [Full Text] [Related]
20. Percutaneous microwave ablation on management of hereditary renal cell carcinoma in Von Hippel-Lindau disease.
Chen J; Zheng L; Zhang W; Wang Z; Yu J; Liang P
Int J Hyperthermia; 2024; 41(1):2308079. PubMed ID: 38346873
[TBL] [Abstract] [Full Text] [Related]
[Next]
